Atlas Trials

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)

Clinical trial NCT01308645 · UNKNOWN

Trial details

NCT number
NCT01308645
Sponsor
SBPharmaceutical IND, Co., LTD
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2010-12-01
Primary completion
2011-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.